France · Biotechnology startup
France · Valneva
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Funding reportedLast round: Grant
What company datasets say Valneva raised
Funding, as reported
Reported in all786.2Min the source's currency
Rounds15
Last roundGrant
Last round dateJul 2024
Investors listed8
Founders and team
From Valneva's own website: 4 on the team.
- Dipal PatelChief Commercial Officer
- Peter BühlerChief Financial Officer
- Petra PesendorferChief People Officer
- Vincent DequenneChief Operating Officer
On a portfolio page
Investors who name them
Each firm lists Valneva on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in France
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Valneva in front of investors. Or tell us what we have wrong.